The median effective concentration of propofol with different doses of esketamine during gastrointestinal endoscopy in elderly patients: A randomized controlled trial

Hua Yang,Qian Zhao,Hai‐yan Chen,Wen Liu,Tong Ding,Bin Yang,Jin‐Chao Song
DOI: https://doi.org/10.1111/bcp.15072
2021-10-08
British Journal of Clinical Pharmacology
Abstract:BackgroundPropofol may result in hypotension, bradycardia, and loss of protective reflexes, especially in elderly patients, while esketamine, a N-methyl-D-aspartate receptor antagonist, has analgesic, anaesthetic and sympathomimetic properties and is known to cause less cardiorespiratory depression. We hypothesized that esketamine may reduce the median effective concentration (EC50) of propofol and co-administration cause less likely to produce hypotension during gastrointestinal endoscopy in elderly patients. MethodsNinety elderly patients, aged 65-89 years, undergoing gastrointestinal endoscopy were randomly assigned into three groups: SK0 (control) group (0 mg/kg esketamine), SK0.25 group (0.25 mg/kg esketamine), and SK0.5 group (0.5 mg/kg esketamine). Anaesthesia was achieved by plasma target-controlled infusion of propofol with different bolus doses of esketamine. The EC50 of propofol for gastrointestinal endoscopy was determined by using the up-and-down method of Dixon. The initial plasma target concentration is 2.5 μg/ml and the adjacent concentration gradient is 0.5 μg/mL. Cardiovascular variables were also measured. ResultsPropofol EC50s and its 95% confidence interval for gastrointestinal endoscopy in elderly patients were 3.69 (2.59-4.78), 2.45 (1.85-3.05) and 1.71 (1.15-2.27) μg/mL in SK0, SK0.25 and SK0.5 group (P < 0.05). The average percent change from baseline mean arterial pressure (MAP) was -19.7 (7.55), -15.2 (7.14) and -10.1 (6.73), in SK0, SK0.25 and SK0.5 group (P<0.001). ConclusionsCombination medication of propofol with esketamine reduced the propofol EC50 during gastrointestinal endoscopy in elderly patients compared with administration of propofol without esketamine. Increasing doses of SK with propofol are less likely to produce hypotension with shorter recovery time.
pharmacology & pharmacy
What problem does this paper attempt to address?